tbResList Print — Riv Rivastigmine

Filters: qv=345, qv2=%, rfv=%

Product

Riv Rivastigmine
Description: <b>Rivastigmine</b><br>
-FDA approved for for mild to moderate AD and Parkinson’s disease dementia<br>
-Dual inhibitor of acetylcholinesterase(AChE) and butyrylcholinesterase (BuChE)<br>
<br>
<br>

Pathway results for Effect on Cancer / Diseased Cells

Total Targets: 0

Pathway results for Effect on Normal Cells

Redox & Oxidative Stress ⓘ

ROS↓, 1,  

Immune & Inflammatory Signaling ⓘ

Inflam↓, 1,  

Synaptic & Neurotransmission ⓘ

AChE↓, 1,  

Protein Aggregation ⓘ

Aβ↓, 1,  

Functional Outcomes ⓘ

cognitive↑, 1,  
Total Targets: 5

Research papers

Year Title Authors PMID Link Flag
2024Natural acetylcholinesterase inhibitors: A multi-targeted therapeutic potential in Alzheimer's diseaseKumar Gajendra—https://www.sciencedirect.com/science/article/pii/S27724174240002680